This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Allergic Rhinitis
and you are
between 18 and 60
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (loratadine + pseudoephedrine sulfate - Schering Plough) in patients with allergic rhinitis by quantification of the scores of clinical parameters (signs and symptoms) and laboratory (nasal flow) down through time.

Provided treatments

  • Drug: Loratadine + Pseudoephedrine sulfate

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01055756. The sponsor of the trial is Azidus Brasil and it is looking for 32 volunteers for the current phase.
Official trial title: